Search results for "Keeping tabs"
Spotlight on interventions for the underserved
Project ECHO for diabetes lowered HbA1c levels in patients at federally qualified health centers, one study found, but another trial did not identify any improvements in glycemic control from providing patients on Medicaid with medically tailored meals.
https://diabetes.acponline.org/archives/2025/01/10/5.htm
10 Jan 2025
Spotlight on GLP-1 receptor agonists and suicidality
Several recent studies did not find an association between glucagon-like peptide-1 (GLP-1) receptor agonists and suicidality, but one analysis identified a potential risk in patients with mental health issues before starting semaglutide.
https://diabetes.acponline.org/archives/2024/09/13/5.htm
13 Sep 2024
Spotlight on younger-onset diabetes
One recent study found significantly elevated mortality risk in patients diagnosed with diabetes before age 40 years, while another reported high rates of diabetes remission among adolescents who underwent bariatric surgery. The NIH announced a large new study of youth-onset diabetes.
https://diabetes.acponline.org/archives/2024/11/08/5.htm
8 Nov 2024
Spotlight on liver health in diabetes
A review compared liver outcomes for most classes of diabetes drugs, while a retrospective study looked at glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors head to head. Another study offered a new score for metabolic dysfunction-associated steatotic liver disease.
https://diabetes.acponline.org/archives/2024/10/11/5.htm
11 Oct 2024
Spotlight on perceptions of glycemic control
Patients' perceptions of their glycemic control may have more effect on their psychological well-being than actual glycemic measurements, according to two new studies.
https://diabetes.acponline.org/archives/2024/08/09/5.htm
9 Aug 2024
Spotlight on comparisons within diabetes drug classes
One review found tirzepatide to have more effect on glycemic outcomes than other glucagon-like peptide-1 receptor agonists, while another showed several sodium-glucose cotransporter-2 inhibitors to have similar effects on cardiovascular outcomes.
https://diabetes.acponline.org/archives/2024/02/09/5.htm
9 Feb 2024
Spotlight on GLP-1 receptor agonists
Cost and access issues were the focus of multiple recent articles about glucagon-like peptide-1 (GLP-1) and dual glucose-dependent insulinotropic polypeptide receptor agonists, while the latest research on these drug classes highlighted their clinical benefits.
https://diabetes.acponline.org/archives/2024/12/13/5.htm
13 Dec 2024
Spotlight on limitations of the HbA1c test
A recent position statement called for use of one-hour glucose tolerance testing for diabetes diagnosis, a review described limitations of point-of-care HbA1c testing, and a study identified differences in the relationship between fasting glucose and HbA1c level by race, age, and sex.
https://diabetes.acponline.org/archives/2024/04/12/5.htm
12 Apr 2024
Spotlight on novel therapies for type 1 diabetes
Manufacturer trials reported the effects of weekly insulin and teplizumab in patients with type 1 diabetes, while recent reviews looked at preventing beta-cell loss with various therapeutics and using drugs approved for type 2 diabetes to combat chronic kidney disease in type 1.
https://diabetes.acponline.org/archives/2023/11/10/5.htm
10 Nov 2023
Spotlight on hypoglycemia in older patients
One recent study highlighted the problem of physical food insecurity and another identified predictors of impaired hypoglycemia awareness, both in older diabetes patients. A review suggested varying continuous glucose monitoring targets for older patients by their health status.
https://diabetes.acponline.org/archives/2024/06/14/5.htm
14 Jun 2024